Orthofix International (OFIX) Misses Q1 EPS by 45c ; offers Guidance
Tweet
Share
E-mailGet Alerts OFIX Hot Sheet
Price: $9.05 -2.58%
EPS Growth %: +52.6%
Financial Fact:
Operating Expenses, Total: 69.35M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +52.6%
Financial Fact:
Operating Expenses, Total: 69.35M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Orthofix International (NASDAQ: OFIX) reported Q1 EPS of ($0.95), $0.45 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $188.6 million versus the consensus estimate of $184.29 million.
GUIDANCE:
Orthofix International sees FY2024 revenue of $790-795 million, versus the consensus of $791 million.
For earnings history and earnings-related data on Orthofix International (OFIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
- HSBC lifts S&P 500 year-end target
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
